Cancer Research, Clinical Trials, and Drug Costs
A current research project at Tennessee State University is studying what creates higher cancer rates in specific groups compared to the rest of the population.
A clinical trial in Wisconsin shows promise is the treatment and remission of a rare blood cancer.
This article highlights a new technique that researchers have developed to look at live cells to aid in cancer diagnosis.
Due to a decision by the NHS, breast cancer patients will not be given the drug Kadcyla that could extend their lives due to the high costs.
Time reports that research in immunotherapy continues to show promise in the treatment of various blood cancers.